Institutional investors purchased a net $15.2 million shares of GRFS during the quarter ended March 2017 and now own 62.59% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
AKO CAPITAL LLP Bought 11.7 Million shares of Grifols SA
T. ROWE PRICE INTERNATIONAL LTD. Bought 4.7 Million shares of Grifols SA
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.2 Million shares of Grifols SA